Condition
High Blood Pressure (& [Essential Hypertension])
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed2
Not Yet Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07491510Not ApplicableNot Yet RecruitingPrimary
Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income
NCT07448506Phase 3CompletedPrimary
PHASE III, RANDOMIZED, ACTIVE-COMPARATOR CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF NIFEDIPINE 30MG EXTENDED-RELEASE IN ADULT PATIENTS DIAGNOSED WITH MILD OR MODERATE HYPERTENSION IN COLOMBIA.
NCT07310992Not ApplicableNot Yet RecruitingPrimary
Effect of Meditation as an Adjunct to Cardiac Rehabilitation
NCT02443454Completed
Short and Long-term Results of Arterial Stiffness and Central Aortic Pressure After Kidney Transplantation
Showing all 4 trials